CYRX (CryoPort) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CYRX CryoPort Inc CYRX
71 GF Score
Price $15.24
GF Value $11.06
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is CryoPort Short-term investments?

Short-term investments only applies to insurance companies.

CYRX
71GF Score
CryoPort Inc CYRX
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CryoPort (CYRX) Overvalued in 2026?

Based on GuruFocus' analysis, CryoPort stock appears to be overvalued. The current stock price of $15.24 is trading 37.8% above its estimated GF Value™ of $11.06. GuruFocus considers CryoPort to be Significantly Overvalued.

Key valuation signals for CYRX:

  • Short-term investments:
  • GF Value™: $11.06 vs. price of $15.24 (37.8% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the CYRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CryoPort Business Description

Other Exchanges CKX:Germany
Address 112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
71GF Score

Get the complete analysis for CYRX

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.24
Price
$11.06
GF Value